|
IL6ST expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21529999999692E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.319500E-02 |
| Normal-vs-Stage2 |
1.537330E-03 |
| Normal-vs-Stage3 |
1.04499999997731E-06 |
| Normal-vs-Stage4 |
4.83480000035286E-07 |
| Stage1-vs-Stage2 |
7.195900E-02 |
| Stage1-vs-Stage3 |
1.736380E-03 |
| Stage1-vs-Stage4 |
4.591500E-04 |
| Stage2-vs-Stage3 |
6.045600E-01 |
| Stage2-vs-Stage4 |
2.519200E-01 |
| Stage3-vs-Stage4 |
4.069800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.962830E-04 |
| Normal-vs-AfricanAmerican |
2.34040000046676E-07 |
| Normal-vs-Asian |
9.374000E-01 |
| Caucasian-vs-AfricanAmerican |
3.319400E-03 |
| Caucasian-vs-Asian |
4.163000E-01 |
| AfricanAmerican-vs-Asian |
5.194400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04209999999927E-05 |
| Normal-vs-Female |
1.899730E-03 |
| Male-vs-Female |
4.225000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.302700E-03 |
| Normal-vs-Age(41-60Yrs) |
9.192700E-04 |
| Normal-vs-Age(61-80Yrs) |
8.47790000000348E-05 |
| Normal-vs-Age(81-100Yrs) |
7.113900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.775400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.969200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.130600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.482800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.863800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.710400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.126000E-01 |
| Normal-vs-Grade 2 |
2.586400E-02 |
| Normal-vs-Grade 3 |
1.028350E-04 |
| Normal-vs-Grade 4 |
3.23579996130974E-09 |
| Grade 1-vs-Grade 2 |
9.046600E-01 |
| Grade 1-vs-Grade 3 |
4.430800E-01 |
| Grade 1-vs-Grade 4 |
2.242400E-02 |
| Grade 2-vs-Grade 3 |
6.476500E-02 |
| Grade 2-vs-Grade 4 |
1.76428999999478E-05 |
| Grade 3-vs-Grade 4 |
4.962200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.552600E-01 |
| Normal-vs-ccB subtype |
7.59580000000426E-05 |
| ccA subtype-vs-ccB subtype |
2.281200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.835800E-04 |
| Normal-vs-N1 |
1.230800E-01 |
| N0-vs-N1 |
5.581000E-01 |
|
|
